BFG
TXG icon

Bleakley Financial Group’s 10x Genomics TXG Stock Holding History

Bleakley Financial Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,189
Closed -$234K – 1030
2023
Q4 		$234K Buy
+4,189
New +$182K 0.01% 812
2023
Q3 		– Sell
-4,621
Closed -$258K – 953
2023
Q2 		$258K Buy
4,621
+392
+9% +$21.2K 0.01% 764
2023
Q1 		$236K Buy
+4,229
New +$197K 0.01% 771

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bleakley Financial Group's TXG Position: Q1 2024 in Review

Bleakley Financial Group sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 4,189 shares — an estimated $234K sold.

Bleakley Financial Group first reported a position in TXG in Q1 2023 and held it in 3 quarters. The position peaked at $258K in Q2 2023. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Bleakley Financial Group reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
  • Bleakley Financial Group sold 4,189 10x Genomics shares in Q1 2024, an estimated $234K.
  • Bleakley Financial Group first reported a position in 10x Genomics in Q1 2023 and held it in 3 quarters.
  • Bleakley Financial Group's 10x Genomics position peaked at $258K in Q2 2023.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Bleakley Financial Group's 13F filing for Q1 2024, filed 8 May 2024.